Structures by: Chow P. S.
Total: 110
1:2 Cocrystal of nitrofurantoin and 4-hydroxybenzamide
C8H6N4O5,C7H7NO2,C7H7NO2
Crystal Growth & Design (2012) 12, 12 5925
a=6.810(2)Å b=15.644(5)Å c=21.120(7)Å
α=90.00° β=93.260(7)° γ=90.00°
1:1 Cocrystal of nitrofurantoin and phenazine (two half molecules)
C20H14N6O5
Crystal Growth & Design (2012) 12, 12 5925
a=8.7234(17)Å b=9.969(2)Å c=11.547(2)Å
α=65.43(3)° β=86.27(3)° γ=84.23(3)°
1:1:1 Cocrystal of nitrofurantoin, melamine and water
C8H6N4O5,C3H6N6,H2O
Crystal Growth & Design (2012) 12, 12 5925
a=6.8748(14)Å b=10.541(2)Å c=11.088(2)Å
α=75.64(3)° β=82.27(3)° γ=84.85(3)°
1:1/2:1 Cocrystal of nitrofurantoin, 4,4'-bipyridyl and water
C13H12N5O6
Crystal Growth & Design (2012) 12, 12 5925
a=31.804(6)Å b=6.7822(14)Å c=13.672(3)Å
α=90.00° β=99.86(3)° γ=90.00°
1:1:1 Cocrystal of nitrofurantoin, 4,4'-bipyridyl ethane and water
C28H28N10O12
Crystal Growth & Design (2012) 12, 12 5925
a=6.4093(13)Å b=13.597(3)Å c=19.138(4)Å
α=106.54(3)° β=93.68(3)° γ=100.76(3)°
C38H41Cl2NO17S
C38H41Cl2NO17S
Crystal Growth & Design (2012) 12, 12 5858
a=8.7080(17)Å b=19.666(4)Å c=11.532(2)Å
α=90.00° β=96.70(3)° γ=90.00°
Form I of a 1:1 salt of HAL and ACE-H
C25H28ClFN2O6S
Crystal Growth & Design (2014) 14, 5 2542
a=26.571(5)Å b=9.925(2)Å c=21.954(4)Å
α=90.00° β=120.59(3)° γ=90.00°
Metaxalone
C12H15NO3
Crystal Growth & Design (2011) 11, 9 4101
a=10.101(2)Å b=15.505(3)Å c=7.1101(14)Å
α=90.00° β=91.23(3)° γ=90.00°
Form II 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid
C9H11NO2,C7H4N2O6
Crystal Growth & Design (2010) 10, 5 2229
a=7.3269(15)Å b=9.952(2)Å c=11.855(2)Å
α=85.17(3)° β=74.65(3)° γ=87.56(3)°
Acetonitrile solvate of 1:1 cocrystal of ethenzamide and 3,5-dinitrobenzoic acid
C9H11NO2,C7H4N2O6
Crystal Growth & Design (2010) 10, 5 2229
a=7.663(3)Å b=8.193(3)Å c=15.830(6)Å
α=74.952(15)° β=82.419(15)° γ=80.051(17)°